Trial ID or NCT#

NCT03288714

Status

RECRUITING

Purpose

This is a double-blind, sham controlled, multi-center study to confirm the safety and efficacy of synchronized transcranial magnetic stimulation (sTMS) for the treatment of patients currently experiencing an episode of depression who have failed to respond to at least one (1) antidepressant medication. Patients will be randomly assigned to either active or sham therapy and will undergo daily treatments for a period of time. Following completion of blinded treatments, patients may be eligible for a course of open label treatments.

Official Title

A Prospective, Multicenter, Double-Blind, Sham-Controlled Adaptive Design Study to Confirm the Safety and Efficacy of NEST sTMS in Subjects With Major Depressive Disorder Who Have Not Responded to at Least One Antidepressant Medication in the Current Episode

Eligibility Criteria

Ages Eligible for Study: 22 Years to 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Mahendra Bhati
Neuropsychiatrist
Clinical Associate Professor, Psychiatry and Behavioral Sciences Clinical Associate Professor, Neurosurgery

Contact us to find out if this trial is right for you.

CONTACT

Olivia Jang
(650) 497-1890